Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Von Eschenbach Is Likely Nominee For Permanent FDA Commissioner

This article was originally published in The Gray Sheet

Executive Summary

FDA Acting Commissioner and National Cancer Institute Director Andrew von Eschenbach will likely be nominated by President George W. Bush as the permanent head of the agency, former FDA Associate Commissioner for External Relations Peter Pitts said March 9
Advertisement

Related Content

Acting Chief von Eschenbach Brings Zeal For Imaging To FDA
Commissioner Von Eschenbach: NCI Director Named Acting Head Of FDA
Commissioner Von Eschenbach: NCI Director Named Acting Head Of FDA
Advertisement
UsernamePublicRestriction

Register

MT023324

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel